Details of the Drug Reposition

General Information of This Drug (ID: DMEIZ20)

• Drug Name: SL125 (DMEIZ20)

Information on Drug Reposition of This Drug

3 Investigative Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Hyperaldosteronism	DIS3WGAL	5A72	Investigative	[1]
Myocardial fibrosis	DISMOLYU	BC43.20	Investigative	[1]
Congestive heart failure	DIS32MEA	BD10	Investigative	[1]

References

• [1] Reduction of cell proliferation induced by PD166866: an inhibitor of the basic fibroblast growth factor. J Exp Clin Cancer Res. 2007 Sep;26(3):405-9.